Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–96.

CAS  PubMed  Google Scholar 

Yap TA, Gerlinger M, Futreal PA, Pusztai L, Swanton C. Intratumor heterogeneity: seeing the wood for the trees. Science translational medicine. 2012;4(127):127ps10.

Robin AM, Lee I, Kalkanis SN. Reoperation for recurrent glioblastoma multiforme. Neurosurg Clin N Am. 2017;28(3):407–28.

PubMed  Google Scholar 

Hansson J, Martenhed G, Egyházi S, Tani E, Platz A. Analysis of O6-methylguanine-DNA methyltransferase mRNA in fine needle biopsies from human melanoma metastases by reverse transcription and polymerase chain reaction. European journal of cancer (Oxford, England : 1990). 1996;32a(13):2319–26.

Perazzoli G, Prados J, Ortiz R, Caba O, Cabeza L, Berdasco M, et al. Temozolomide resistance in glioblastoma cell lines: implication of MGMT, MMR, P-glycoprotein and CD133 expression. PLoS ONE. 2015;10(10): e0140131.

PubMed  PubMed Central  Google Scholar 

Dai W, Wu A, Li Y, Yu G, Yan X. XPA enhances temozolomide resistance of glioblastoma cells by promoting nucleotide excision repair. Cell Transplant. 2022;31:9636897221092778.

PubMed  Google Scholar 

Zampieri LX, Sboarina M, Cacace A, Grasso D, Thabault L, Hamelin L, et al. Olaparib Is a Mitochondrial Complex I Inhibitor That Kills Temozolomide-Resistant Human Glioblastoma Cells. International journal of molecular sciences. 2021;22(21).

Hunter C, Smith R, Cahill DP, Stephens P, Stevens C, Teague J, et al. A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. Can Res. 2006;66(8):3987–91.

CAS  Google Scholar 

Reisman SA, Gahir SS, Lee CI, Proksch JW, Sakamoto M, Ward KW. Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates. Drug Des Dev Ther. 2019;13:1259–70.

CAS  Google Scholar 

Probst BL, Trevino I, McCauley L, Bumeister R, Dulubova I, Wigley WC, et al. RTA 408, a novel synthetic triterpenoid with broad anticancer and anti-inflammatory activity. PLoS ONE. 2015;10(4): e0122942.

PubMed  PubMed Central  Google Scholar 

Kong L, Li S, Liao Q, Zhang Y, Sun R, Zhu X, et al. Oleanolic acid and ursolic acid: novel hepatitis C virus antivirals that inhibit NS5B activity. Antiviral Res. 2013;98(1):44–53.

CAS  PubMed  Google Scholar 

Guerrero-Hue M, Rayego-Mateos S, Vázquez-Carballo C, Palomino-Antolín A, García-Caballero C, Opazo-Rios L, et al. Protective Role of Nrf2 in Renal Disease. Antioxidants (Basel, Switzerland). 2020;10(1).

Hu L, Cao Y, Chen H, Xu L, Yang Q, Zhou H, et al. The novel nrf2 activator omaveloxolone regulates microglia phenotype and ameliorates secondary brain injury after intracerebral hemorrhage in mice. Oxid Med Cell Longev. 2022;2022:4564471.

PubMed  PubMed Central  Google Scholar 

Sun X, Xie Z, Hu B, Zhang B, Ma Y, Pan X, et al. The Nrf2 activator RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-κb signaling. Redox Biol. 2020;28: 101309.

CAS  PubMed  Google Scholar 

Deeb D, Gao X, Jiang H, Dulchavsky SA, Gautam SC. Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR. Prostate. 2009;69(8):851–60.

CAS  PubMed  Google Scholar 

Deeb D, Gao X, Arbab AS, Barton K, Dulchavsky SA, Gautam SC. CDDO-Me: a novel synthetic triterpenoid for the treatment of pancreatic cancer. Cancers. 2010;2(4):1779–93.

CAS  PubMed  PubMed Central  Google Scholar 

Gibellini L, Bianchini E, De Biasi S, Nasi M, Cossarizza A, Pinti M. Natural compounds modulating mitochondrial functions. Evidence-Based Complementary Altern Med eCAM. 2015;2015: 527209.

Google Scholar 

Lee SY. Temozolomide resistance in glioblastoma multiforme. Genes Dis. 2016;3(3):198–210.

PubMed  PubMed Central  Google Scholar 

Lee KT, Hsu YC, Lieu AS, Lin CL, Tsai TH. Omaveloxolone suppresses cell growth and causes cell cycle arrest by downregulating CDC20 expression in glioblastoma cells both in vitro and in vivo. J Cell Mol Med. 2025;29(11): e70607.

PubMed  PubMed Central  Google Scholar 

Sottoriva A, Vermeulen L, Tavaré S. Modeling evolutionary dynamics of epigenetic mutations in hierarchically organized tumors. PLoS Comput Biol. 2011;7(5): e1001132.

CAS  PubMed  PubMed Central  Google Scholar 

Sottoriva A, Spiteri I, Piccirillo SG, Touloumis A, Collins VP, Marioni JC, et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci USA. 2013;110(10):4009–14.

CAS  PubMed  PubMed Central  Google Scholar 

Jeong CH, Joo SH. Downregulation of reactive oxygen species in apoptosis. J Cancer Prevent. 2016;21(1):13–20.

Google Scholar 

Sporn MB. Approaches to prevention of epithelial cancer during the preneoplastic period. Can Res. 1976;36(7 pt 2):2699–702.

CAS  Google Scholar 

Yan W, Yang J, Tang H, Xue L, Chen K, Wang L, et al. Flavonoids from the stems of Millettia pachyloba Drake mediate cytotoxic activity through apoptosis and autophagy in cancer cells. J Adv Res. 2019;20:117–27.

CAS  PubMed  PubMed Central  Google Scholar 

Tafrihi M, Imran M, Tufail T, Gondal TA, Caruso G, Sharma S, et al. The wonderful activities of the genus mentha: not only antioxidant properties. Molecules (Basel, Switzerland). 2021;26(4).

Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Current Biol CB. 2014;24(10):R453–62.

CAS  Google Scholar 

Cross CE, Halliwell B, Borish ET, Pryor WA, Ames BN, Saul RL, et al. Oxygen radicals and human disease. Ann Intern Med. 1987;107(4):526–45.

CAS  PubMed  Google Scholar 

Shuvalov O, Kirdeeva Y, Daks A, Fedorova O, Parfenyev S, Simon HU, et al. Phytochemicals target multiple metabolic pathways in cancer. Antioxidants (Basel, Switzerland). 2023;12(11).

Thayyullathil F, Chathoth S, Hago A, Patel M, Galadari S. Rapid reactive oxygen species (ROS) generation induced by curcumin leads to caspase-dependent and -independent apoptosis in L929 cells. Free Radical Biol Med. 2008;45(10):1403–12.

CAS  Google Scholar 

Berndtsson M, Hägg M, Panaretakis T, Havelka AM, Shoshan MC, Linder S. Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA. Int J Cancer. 2007;120(1):175–80.

CAS  PubMed  Google Scholar 

Cheng G, Lanza-Jacoby S. Metformin decreases growth of pancreatic cancer cells by decreasing reactive oxygen species: role of NOX4. Biochem Biophys Res Commun. 2015;465(1):41–6.

CAS  PubMed  Google Scholar 

Hail N Jr. Mitochondrial reactive oxygen species affect sensitivity to curcumin-induced apoptosis. Free Radical Biol Med. 2008;44(7):1382–93.

Google Scholar 

Moi P, Chan K, Asunis I, Cao A, Kan YW. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci USA. 1994;91(21):9926–30.

CAS  PubMed  PubMed Central  Google Scholar 

Soares MP, Bach FH. Heme oxygenase-1: from biology to therapeutic potential. Trends Mol Med. 2009;15(2):50–8.

CAS  PubMed  Google Scholar 

Borella R, Forti L, Gibellini L, De Gaetano A, De Biasi S, Nasi M, et al. Synthesis and anticancer activity of CDDO and CDDO-Me, two derivatives of natural triterpenoids. Molecules. 2019;24(22).

Dumont M, Wille E, Calingasan NY, Tampellini D, Williams C, Gouras GK, et al. Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer’s disease. J Neurochem. 2009;109(2):502–12.

CAS  PubMed  PubMed Central  Google Scholar 

Neymotin A, Calingasan NY, Wille E, Naseri N, Petri S, Damiano M, et al. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radical Biol Med. 2011;51(1):88–96.

CAS  Google Scholar 

Fruman DA, Rommel C. PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discovery. 2014;13(2):140–56.

CAS  PubMed  Google Scholar 

Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem. 2004;73:39–85.

CAS  PubMed  Google Scholar 

Kaina B, Ochs K, Grösch S, Fritz G, Lips J, Tomicic M, et al. BER, MGMT, and MMR in defense against alkylation-induced genotoxicity and apoptosis. Prog Nucleic Acid Res Mol Biol. 2001;68:41–54.

CAS  PubMed  Google Scholar